Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma.
about
β-adrenergic signaling in mice housed at standard temperatures suppresses an effector phenotype in CD8(+) T cells and undermines checkpoint inhibitor therapy.Beta-adrenergic receptors are expressed across diverse cancers.Implicating anaesthesia and the perioperative period in cancer recurrence and metastasis.Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response.Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma.The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients
P2860
Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Propranolol induces a favourab ...... spontaneous model of melanoma.
@en
Propranolol induces a favourab ...... spontaneous model of melanoma.
@nl
type
label
Propranolol induces a favourab ...... spontaneous model of melanoma.
@en
Propranolol induces a favourab ...... spontaneous model of melanoma.
@nl
prefLabel
Propranolol induces a favourab ...... spontaneous model of melanoma.
@en
Propranolol induces a favourab ...... spontaneous model of melanoma.
@nl
P2093
P2860
P356
P1433
P1476
Propranolol induces a favourab ...... spontaneous model of melanoma
@en
P2093
Frédérique-Anne Le Gal
Ludovic Jean Wrobel
Masashi Kato
Renée Lengagne
P2860
P304
77825-77837
P356
10.18632/ONCOTARGET.12833
P407
P577
2016-11-01T00:00:00Z